Valuation: Bausch Health Companies Inc.

Capitalization 2.01B 1.7B 1.56B 1.47B 2.74B 191B 2.76B 18.48B 7.21B 91B 7.52B 7.37B 315B P/E ratio 2026 *
-10.7x
P/E ratio 2027 * 3.45x
Enterprise value 20.41B 17.32B 15.86B 14.95B 27.89B 1,944B 28.11B 188B 73.41B 926B 76.57B 74.96B 3,204B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.78x
Free-Float
68.19%
Yield 2026 *
-
Yield 2027 * -
1 day-6.61%
1 week-2.89%
Current month-6.12%
1 month-4.11%
3 months-11.68%
6 months-21.15%
Current year-22.73%
1 week 5.32
Extreme 5.3201
5.89
1 month 5.32
Extreme 5.3201
6.29
Current year 4.93
Extreme 4.93
8
1 year 4.41
Extreme 4.41
8.68
3 years 3.96
Extreme 3.96
11.46
5 years 3.96
Extreme 3.96
32.54
10 years 3.96
Extreme 3.96
34.8
Manager TitleAgeSince
Chief Executive Officer 63 2022-05-09
Director of Finance/CFO 60 2024-08-18
Chief Tech/Sci/R&D Officer - 2024-12-01
Director TitleAgeSince
Chairman 69 2022-05-09
Director/Board Member 63 2022-05-09
Director/Board Member 56 2016-06-13
Change 5d. change 1-year change 3-years change Capi.($)
-6.61%-2.89%+16.99%-7.73% 2.01B
+1.95%-0.10%+31.64%+122.02% 862B
+0.05%-1.24%+43.58%+37.54% 533B
+0.61%-2.58%+9.85%+38.33% 358B
+1.49%-0.38%+22.40%+11.63% 328B
-0.01%+1.32%+31.48%+12.46% 286B
+0.58%+0.85%+24.89%+23.74% 279B
-0.09%-1.62%+46.48%-5.33% 275B
+0.57%+5.63%-31.58%-48.62% 210B
-0.64%+1.77%+23.97%+41.89% 178B
Average -0.03%-0.25%+21.97%+22.59% 331.09B
Weighted average by Cap. +0.75%-0.43%+26.51%+44.92%

Financials

2026 *2027 *
Net sales 10.73B 9.11B 8.34B 7.87B 14.67B 1,023B 14.79B 98.93B 38.61B 487B 40.27B 39.43B 1,686B 10.71B 9.08B 8.32B 7.84B 14.63B 1,020B 14.75B 98.67B 38.51B 486B 40.17B 39.32B 1,681B
Net income -188M -159M -146M -138M -257M -17.89B -259M -1.73B -675M -8.52B -704M -690M -29.48B 588M 499M 457M 431M 804M 56.02B 810M 5.42B 2.12B 26.68B 2.21B 2.16B 92.33B
Net Debt 18.4B 15.62B 14.3B 13.48B 25.15B 1,753B 25.35B 170B 66.2B 835B 69.04B 67.59B 2,889B 17.1B 14.51B 13.29B 12.53B 23.38B 1,629B 23.56B 158B 61.53B 776B 64.17B 62.82B 2,686B
Logo Bausch Health Companies Inc.
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Employees
20,300
Date Price Change Volume
26-05-11 5.370 $ -6.61% 2,037,499
26-05-08 5.750 $ +0.35% 1,250,645
26-05-07 5.730 $ +1.42% 2,125,071
26-05-06 5.650 $ +0.18% 1,227,154
26-05-05 5.640 $ +1.99% 1,290,594
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
5.370USD
Average target price
7.571USD
Spread / Average Target
+40.99%

Quarterly revenue - Rate of surprise